You are currently visiting the test version of the radboud Dspace repository. To access the production instance, you can navigate to: https://repository.ubn.ru.nl

Fulltext:
81796.pdf
Embargo:
until further notice
Size:
206.0Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2009Source
Journal of Clinical Epidemiology, 62, 1, (2009), pp. 47.e1-10ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Health Evidence
IQ Healthcare
Internal Medicine
Endocrinology
Former Organization
Centre for Quality of Care Research
Epidemiology, Biostatistics & HTA
Journal title
Journal of Clinical Epidemiology
Volume
vol. 62
Issue
iss. 1
Page start
p. 47.e1
Page end
p. 10
Subject
IGMD 6: Hormonal regulation; NCEBP 1: Molecular epidemiology; NCEBP 2: Evaluation of complex medical interventions; ONCOL 2: Age-related aspects of cancer; ONCOL 3: Translational research; Internal Medicine Radboud University Medical CenterAbstract
OBJECTIVE: The objective was to investigate whether it is justified to discourage trials with less than 80% power. Trials with low power are unlikely to produce conclusive results, but their findings can be used by pooling then in a meta-analysis. However, such an analysis may be biased, because trials with low power are likely to have a nonsignificant result and are less likely to be published than trials with a statistically significant outcome. STUDY DESIGN AND SETTING: We simulated several series of studies with varying degrees of publication bias and then calculated the "real" one-sided type I error and the bias of meta-analyses with a "nominal" error rate (significance level) of 2.5%. RESULTS: In single trials, in which heterogeneity was set at zero, low, and high, the error rates were 2.3%, 4.7%, and 16.5%, respectively. In multiple trials with 80%-90% power and a publication rate of 90% when the results were nonsignificant, the error rates could be as high as 5.1%. When the power was 50% and the publication rate of non-significant results was 60%, the error rates did not exceed 5.3%, whereas the bias was at most 15% of the difference used in the power calculation. CONCLUSION: The impact of publication bias does not warrant the exclusion of trials with 50% power.
This item appears in the following Collection(s)
- Academic publications [244578]
- Electronic publications [132441]
- Faculty of Medical Sciences [92890]
Upload full text
Use your RU or RadboudUMC credentials to log in with SURFconext to upload a file for processing by the repository team.